INSIGHTS ON DRUG DEVELOPMENT
-
Development Of A High Sensitivity SPE-LC-MS/MS Assay
Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.
-
How To Power MRD Assessment And Multi-Cancer Detection Research
New advances in MCED and MRD monitoring are transforming cancer care. Fueled by NGS insights, see how these approaches are shifting treatment decisions toward more proactive strategies.
-
Keeping The Momentum In Pandemic Preparedness
Learn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.
-
Highly Sensitive ELISAs In 90 Minutes
Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.
-
ITC: Unveiling Its Role And Importance In Drug Design6/26/2025
Explore how Isothermal Titration Calorimetry empowers drug discovery, as well as learn about ITC fundamentals, how to eliminate weak candidates, and how to optimize development decisions.
-
How Biocatalysts Address Process Development Issues7/23/2026
Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.
-
384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay9/18/2024
Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.
-
Unlocking The Next Wave Of Cancer Vaccines4/21/2026
Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.
-
The High Intensity Sweeteners Neotame And Sucralose8/5/2026
Learn how high-intensity sweeteners can mask bitter aftertastes and support patient adherence, with practical guidance on stability, safety, dosage-form applications, and market perception.
DRUG DEVELOPMENT SOLUTIONS
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.
-
Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
-
Explore a diverse range of immunoassays for hormone analysis, neurodegeneration, autoimmunity, and salivary diagnostics—each designed for high sensitivity, reproducibility, and ease of use.
-
Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.
With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.